• Je něco špatně v tomto záznamu ?

The incidence and results of laser enhancement after cataract and refractive surgery with trifocal lens implantation

D. Barakova, D. Jordanovova, M. Sramka, A. Kaluzakova, M. Sajdikova

. 2022 ; 166 (2) : 222-227. [pub] 20210204

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22014557

PURPOSE: To evaluate the incidence of laser enhancement following cataract surgery and refractive lens exchange (RLE) with FineVision Micro F trifocal lens implantation (PhysIOL, Liège, Belgium). METHODS: Retrospective study of patients who had undergone cataract or RLE surgery and had received a FineVision Micro F intraocular lens. Laser enhancement of residual refractive error was determined. Visual acuity (VA) assessments were performed before and after surgery: uncorrected distance VA (UCDVA), best-corrected distance VA (BCDVA), uncorrected near VA (UCNVA), plus preoperative and postoperative spherical equivalent (SE) assessments. RESULTS: Of the 1129 eyes from 596 patients, 61 (5.4%) required laser enhancement to correct residual refractive error (by group: 30/679 eyes [4.4%] cataract; 31/450 eyes [6.9%] RLE). Eleven eyes received FemtoLASIK; 50 eyes received PRK. Mean UCDVA before laser enhancement was 0.26±0.19 logMAR and 0.24±0.14 in the FemtoLASIK and PRK groups, respectively. After laser enhancement, these were 0.04±0.05 logMAR and 0.13±0.19, respectively; BCDVA values were 0.00±0.00 logMAR in the FemtoLASIK group and 0.06±0.11 in the PRK group. Laser enhancement improved UCNVA (Jaeger) from 2-3 to 1-2 in both groups. Enhancement reduced preoperative SE of -0.39±0.99 D and -0.53±0.58 D (FemtoLASIK and PRK groups, respectively) to 0.24±0.36 D and 0.04±0.47 D. CONCLUSIONS: The FineVision Micro F trifocal lens is an effective solution for gaining increased spectacle independence. The incidence of residual refractive error requiring laser enhancement is low, and laser procedures are a safe and effective solution for improving the quality of vision and patient satisfaction. SYNOPSIS: Laser enhancement rates and outcomes were determined following cataract / refractive lens exchange surgery that used a trifocal IOL. Enhancement was safe and effective and rates were low (5.4%).

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22014557
003      
CZ-PrNML
005      
20230308115401.0
007      
ta
008      
220602s2022 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2021.010 $2 doi
035    __
$a (PubMed)33542541
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Baráková, Drahomíra, $u Gemini Eye Clinic, Prague, Czech Republic $u Department of Ophthalmology, Motol University Hospital, Prague, Czech Republic $d 1955- $7 xx0000259
245    14
$a The incidence and results of laser enhancement after cataract and refractive surgery with trifocal lens implantation / $c D. Barakova, D. Jordanovova, M. Sramka, A. Kaluzakova, M. Sajdikova
520    9_
$a PURPOSE: To evaluate the incidence of laser enhancement following cataract surgery and refractive lens exchange (RLE) with FineVision Micro F trifocal lens implantation (PhysIOL, Liège, Belgium). METHODS: Retrospective study of patients who had undergone cataract or RLE surgery and had received a FineVision Micro F intraocular lens. Laser enhancement of residual refractive error was determined. Visual acuity (VA) assessments were performed before and after surgery: uncorrected distance VA (UCDVA), best-corrected distance VA (BCDVA), uncorrected near VA (UCNVA), plus preoperative and postoperative spherical equivalent (SE) assessments. RESULTS: Of the 1129 eyes from 596 patients, 61 (5.4%) required laser enhancement to correct residual refractive error (by group: 30/679 eyes [4.4%] cataract; 31/450 eyes [6.9%] RLE). Eleven eyes received FemtoLASIK; 50 eyes received PRK. Mean UCDVA before laser enhancement was 0.26±0.19 logMAR and 0.24±0.14 in the FemtoLASIK and PRK groups, respectively. After laser enhancement, these were 0.04±0.05 logMAR and 0.13±0.19, respectively; BCDVA values were 0.00±0.00 logMAR in the FemtoLASIK group and 0.06±0.11 in the PRK group. Laser enhancement improved UCNVA (Jaeger) from 2-3 to 1-2 in both groups. Enhancement reduced preoperative SE of -0.39±0.99 D and -0.53±0.58 D (FemtoLASIK and PRK groups, respectively) to 0.24±0.36 D and 0.04±0.47 D. CONCLUSIONS: The FineVision Micro F trifocal lens is an effective solution for gaining increased spectacle independence. The incidence of residual refractive error requiring laser enhancement is low, and laser procedures are a safe and effective solution for improving the quality of vision and patient satisfaction. SYNOPSIS: Laser enhancement rates and outcomes were determined following cataract / refractive lens exchange surgery that used a trifocal IOL. Enhancement was safe and effective and rates were low (5.4%).
650    12
$a zkalení zadního pouzdra čočky $7 D058442
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a lasery $7 D007834
650    _2
$a implantace nitrooční čočky $x metody $7 D019654
650    _2
$a spokojenost pacientů $7 D017060
650    12
$a fakoemulzifikace $7 D018918
650    _2
$a protézy - design $7 D011474
650    12
$a refrakční vady $7 D012030
650    _2
$a retrospektivní studie $7 D012189
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jordánová, Dagmar $u Gemini Eye Clinic, Prague, Czech Republic $7 xx0269205
700    1_
$a Sramka, Martin $u Gemini Eye Clinic, Prague, Czech Republic $u Department of Circuit theory/Faculty of Electrical engineering, Czech Technical University in Prague, Czech Republic
700    1_
$a Kaluzakova, Adriana $u Gemini Eye Clinic, Prague, Czech Republic
700    1_
$a Sajdikova, Martina $u Gemini Eye Clinic, Prague, Czech Republic
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $x 1213-8118 $g Roč. 166, č. 2 (2022), s. 222-227
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33542541 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y p $z 0
990    __
$a 20220602 $b ABA008
991    __
$a 20230308115356 $b ABA008
999    __
$a ok $b bmc $g 1824812 $s 1165778
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 166 $c 2 $d 222-227 $e 20210204 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK198 $a Pubmed-20220602

Najít záznam

Citační ukazatele

Možnosti archivace